Legis Daily

To reduce prescription drug costs by allowing the importation and reimportation of certain drugs.

USA115th CongressHR-934| House 
| Updated: 2/10/2017
Keith Ellison

Keith Ellison

Democratic Representative

Minnesota

Cosponsors (1)
Dana Rohrabacher (Republican)

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Personal Drug Importation Fairness Act of 2017 This bill allows a drug to be imported by a person other than the drug's manufacturer if the drug: (1) has the same active ingredients, route of administration, and strength as an approved drug; (2) may be lawfully marketed in, and is imported or reimported from, a country included on a list in this Act that the Food and Drug Administration determines has standards for ensuring drug safety and effectiveness that are at least as protective as U.S. standards; (3) is dispensed by a licensed pharmacist; (4) is shipped directly to, or is imported by, the ultimate consumer; (5) is shipped or imported in quantities that do not exceed a 90-day supply; (6) is accompanied by a copy of a valid prescription; and (7) is not a controlled substance.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Feb 7, 2017
Introduced in House
Feb 7, 2017
Referred to the House Committee on Energy and Commerce.
Feb 10, 2017
Referred to the Subcommittee on Health.
  • February 7, 2017
    Introduced in House


  • February 7, 2017
    Referred to the House Committee on Energy and Commerce.


  • February 10, 2017
    Referred to the Subcommittee on Health.

Health

AfricaAsiaAustraliaCanadaDrug safety, medical device, and laboratory regulationEuropeEuropean UnionIsraelJapanNew ZealandOceaniaPrescription drugsSouth AfricaSwitzerlandTrade restrictions

To reduce prescription drug costs by allowing the importation and reimportation of certain drugs.

USA115th CongressHR-934| House 
| Updated: 2/10/2017
Personal Drug Importation Fairness Act of 2017 This bill allows a drug to be imported by a person other than the drug's manufacturer if the drug: (1) has the same active ingredients, route of administration, and strength as an approved drug; (2) may be lawfully marketed in, and is imported or reimported from, a country included on a list in this Act that the Food and Drug Administration determines has standards for ensuring drug safety and effectiveness that are at least as protective as U.S. standards; (3) is dispensed by a licensed pharmacist; (4) is shipped directly to, or is imported by, the ultimate consumer; (5) is shipped or imported in quantities that do not exceed a 90-day supply; (6) is accompanied by a copy of a valid prescription; and (7) is not a controlled substance.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Feb 7, 2017
Introduced in House
Feb 7, 2017
Referred to the House Committee on Energy and Commerce.
Feb 10, 2017
Referred to the Subcommittee on Health.
  • February 7, 2017
    Introduced in House


  • February 7, 2017
    Referred to the House Committee on Energy and Commerce.


  • February 10, 2017
    Referred to the Subcommittee on Health.
Keith Ellison

Keith Ellison

Democratic Representative

Minnesota

Cosponsors (1)
Dana Rohrabacher (Republican)

Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
AfricaAsiaAustraliaCanadaDrug safety, medical device, and laboratory regulationEuropeEuropean UnionIsraelJapanNew ZealandOceaniaPrescription drugsSouth AfricaSwitzerlandTrade restrictions